glp 1 blindness A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no GLP-1 Agonists—commonly used for weight

CART in energy balance and drug addiction: current insights and mechanisms

Because the body's own production declines with age, illness, and stress, injection therapy is the most direct way to restore intracellular levels

Bifidobacterium breve : Known for its ability to reduce bloating and support smoother bowel movements

Acknowledgments The authors gratefully acknowledge the Xinjiang Horse Industry Association for administrative support, the Zhaosu Stud Farm in Yili Kazakh Autonomous Prefecture for providing experimental animals, the College of Animal Science at Xinjiang Agricultural University for technical expertise, and Xinjiang Chixiao Bojun Animal Husbandry Co., Ltd